The Cannabis Investing Podcast cover image

Glass House's Graham Farrar On Industry Challenges And Opportunities

The Cannabis Investing Podcast

CHAPTER

Is Cannabis a Bad Investment?

Sethany: I don't think, you know, pharma does molecules. And cannabis is not a molecule. If they make it scheduled too, you know what everyone's going to do. They're going to ignore it just like schedule one. Their feds aren't going to come in and enforce on 45 states because they moved it from schedule one to schedule two. Sethany: interstate commerce is actually much quicker, closer than people think. The absolute dollars will continue to go up as the pie gets bigger, even if the slice gets a little bit smaller.

00:00
Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner